Company intelligence / Profile preview

SpineX

Los Angeles, California, United States

Ownership: Private
Development stage: Other

Overview

SpineX has demonstrated in clinical research significant improvements in urinary incontinence (neurogenic bladder) and motor symptoms in cerebral palsy using non-invasive transcutaneous spinal cord neuromodulation. Its main devices, SCONE™ and SCiP™, are in investigational clinical use and recruiting for trials.

Therapeutic areas: NephrologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on SpineX.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SpineX.

Explore the full profile